bold, but I like the confidence #thefutureiseurope
| https://twitter.com/YeldaDemirdogen | |
| https://linkedin.com/in/demirdoegen/ |
Yelda
- 33 Followers
- 98 Following
- 25 Posts
accelerating commercialization of biomaterials | formerly: VC🕵🏻♀️ - corporate👸🏻 - lab🐀 | nerdy about the intersection of science & tech | enthusiastic about plant-based deliciousness
RT @ElliotHershberg
Hot take: the recent acquisition of Prometheus Biosciences by Merck for $11B should be counted as a win for TechBio 👀
You may be saying: that's not TechBio!1!1 😖
Consider suspending skepticism for this analysis:
RT @shelbynewsad
We're creating a collective at the intersection of *tech* and *bio* 🚀🧬
Folks interested in building ambitious companies at this junction should apply - https://tinyurl.com/2p882fzd
Check out our *new* thesis in generative AI/ML + bio here - https://tinyurl.com/2v6u7mzr
cc @FabioZB_I
Compound TechBio Collective
We're starting a collective specifically tailored for people building (or wanting to build) at the intersection of AI/ML and bio. This program kicks off with a breakfast on April 21st in NYC, a Discord community, quarterly 1-on-1 sessions to guide learnings and help make connections. We're also planning to have quarterly calls with those involved in the collective to specifically tailor the experience to the participants. If there are synergies with folks from our network, we'd be delighted to make introductions to potential co-founders! Read more on the Compound TechBio Collective here. Compound is a team spanning bio, AI/ML, and robotics (among other technical areas) and can help at any stage in your ideation process.
RT @EG_Cunningham
🧵9/n
EVERY SINGLE SAMPLE we took in Antarctica as part of our microplastic research contained plastic microfibres.
I found plastic from tourists in the penguin colonies.
We even found a big piece of plastic on the seabed.
RT @MattyKirsh
This post describes the largest opportunities for ML in industrial biotech and a new breed of companies we can expect to see as a result.
https://synbiomba.substack.com/p/techbio-in-industrial-biotechnology
This post describes the largest opportunities for ML in industrial biotech and a new breed of companies we can expect to see as a result.
https://synbiomba.substack.com/p/techbio-in-industrial-biotechnology
RT @PeterOlivier
the question isn't if we should do geoengineering, it's what kind we should be doing. it isn't if we should start, it's how we should continue. it isn't if we should be making decisions like this, it's how to make good ones.
19/
RT @NikoMcCarty
Announcing "Latest in Bio+Tech" 🧬
I've stopped sending out weekly paper lists through the newsletter. Now I'm adding new papers to an AirTable each weekend.
Topics include SynBio, CRISPR, Bio+AI & neurotechnology. I hope it's useful! LMK what I missed.
Latest in Bio+Tech
Every weekend, I round up the latest papers in biology and technology as part of my work with Codon. Topics include: * Gene editing and regulation tools, such as CRISPR-Cas9 * Advances in DNA sequencing and synthesis * Medical breakthroughs, from vaccines to gene therapies * Computational tools to design DNA or proteins * Longevity
RT @olshav
Not sure who needs to hear this, but scientists and engineers do not need an MBA to start a successful company
Not sure who needs to hear this, but scientists and engineers do not need an MBA to start a successful company
RT @zavaindar
UPDATE: Today @nanli @AGoulburn & I are launching @_DimensionCap! A $350M venture fund, built to spec, to meet founders at the cutting most edges of technology & the life sciences 🚀🤖🧬
The world didn't need 'another venture firm'. An open letter to our future entrepreneurs: https://twitter.com/zavaindar/status/1501297099887022086
Zavain Dar on Twitter
“SOME NEWS: after a decade investing in the most brilliant interdisciplinary entrepreneurs on the planet, my best friends & partners @nanli @AGoulburn & I are joining forces on … *something new* ;) “If the path be beautiful, let us not ask where it leads.” - Anatole France”
RT @morgancheatham
i'm interested in helping bio companies make diligence more efficient.
doing so will give all parties leverage (and time), and ultimately, will enable new investors to participate in the bioeconomy.
some other best practices for efficient fundraising: https://morgancheatham.substack.com/p/the-anatomy-of-the-data-room
